Habibian, Mostafa, and Mehdi Dehghani. 2018. “Out-of-Pocket Costs Analysis of Ifosfamide, Epirubicin, and Etoposide (IEV) and Etoposide, Solu-Medrol-Methylprednisolone, High-Dose Ara-C-Cytarabine, and Platinol-Cisplatin (ESHAP) Regimens in the Patients With Relapsed and Refractory Lymphoma in Iran”. Chronic Diseases Journal 6 (2):87-92. https://doi.org/10.22122/cdj.v6i2.270.